Russell Investments Group Ltd. Has $25.85 Million Position in GE HealthCare Technologies Inc. $GEHC

Russell Investments Group Ltd. lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.6% during the 2nd quarter, HoldingsChannel reports. The firm owned 349,008 shares of the company’s stock after selling 28,790 shares during the period. Russell Investments Group Ltd.’s holdings in GE HealthCare Technologies were worth $25,851,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of GEHC. Lineweaver Wealth Advisors LLC bought a new position in GE HealthCare Technologies in the second quarter valued at approximately $592,000. Exome Asset Management LLC bought a new stake in shares of GE HealthCare Technologies during the first quarter worth $2,050,000. Nvwm LLC raised its holdings in shares of GE HealthCare Technologies by 5,483.1% during the second quarter. Nvwm LLC now owns 14,237 shares of the company’s stock worth $1,055,000 after acquiring an additional 13,982 shares during the period. Andra AP fonden lifted its position in GE HealthCare Technologies by 104.9% in the 2nd quarter. Andra AP fonden now owns 59,000 shares of the company’s stock valued at $4,370,000 after acquiring an additional 30,200 shares in the last quarter. Finally, Galvin Gaustad & Stein LLC lifted its position in GE HealthCare Technologies by 7.3% in the 2nd quarter. Galvin Gaustad & Stein LLC now owns 177,929 shares of the company’s stock valued at $13,179,000 after acquiring an additional 12,141 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

GEHC has been the subject of a number of research reports. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Evercore ISI upped their price objective on GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Stifel Nicolaus set a $90.00 price objective on GE HealthCare Technologies in a report on Friday, November 21st. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their target price for the company from $93.00 to $83.00 in a research note on Tuesday, October 7th. Finally, Zacks Research downgraded GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $86.45.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $79.99 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The business has a 50-day moving average of $75.08 and a 200-day moving average of $74.16. The stock has a market capitalization of $36.43 billion, a price-to-earnings ratio of 16.53, a PEG ratio of 3.34 and a beta of 1.13. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.